Paragraph IV Challenges

✉ Email this page to a colleague

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Tradename	Dosage	Generic Name	NDA	ANDAs Submitted	180 Day Exclusivity Status	Submissiondate
BYFAVO	Powder for Injection	remimazolam besylate	212295	1		2024-10-07
QDOLO	Oral Solution	tramadol hydrochloride	214044	1		2024-09-16
CRESEMBA	Capsules	isavuconazonium sulfate	207500	4		2024-09-06
CRESEMBA	For Injection	isavuconazonium sulfate	207501	2		2024-09-06
WINLEVI	Cream	clascoterone	213433	1		2024-08-26
>Tradename	>Dosage	>Generic Name	>NDA	>ANDAs Submitted	>180 Day Exclusivity Status	>Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.